Insider buying last 90 days
No open-market insider purchases were filed for RTO in the last 90 days.
From Form 4 filings, dated to when each was filed.
Rentokil Initial shares slipped on a broader market pullback, closing down 1.98% to £3.52 as the FTSE 100 fell 1.01% and the stock traded 30.55% below its 52-week high reached on April 15. Separately, Goldman Sachs handled share repurchases for Rentokil between October 27 and October 30, with shares intended for cancellation. The ADR was noted trading at $23.57, with H1 results showing EPS doubling to $0.14 and sales beating estimates at $3.589 billion, alongside the launch of new multi-brand digital advancements at Rentokil Terminix.
RTO closed at $23.87, up 1.1%, sitting above its 50-day average of $21.92 but below its 200-day average of $28.17. The GekkoIndex reads 51.4, placing the stock in the Neutral zone. Price remains well below Gekko Fair Value of $37.41, a gap of -36.2%.
The next earnings date falls on 25 February 2027, 102 days away and outside a typical 20-trading-day holding window. No insider, Congress, or unusual options activity appears in the recent windows, and no billionaire or trailblazer holders are recorded. Seasonality from this point in the calendar shows a 5-year average return of 1.4% over the next 20 trading days, rising in 2 of those years. One analyst firm maintains a buy rating with a consensus target of $30.70, implying consensus upside of 28.6%.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Rentokil Initial scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
Averages disagree
Close $23.91 sits between the 50-day ($21.90) and 200-day ($27.99) averages, or the averages disagree.
See the chart51.5, Neutral
Reading 51.5 is in the Neutral zone.
See the GekkoIndex36.4% below
Price is 36.4% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 102 days
Next report Feb 25, 2027, 102 days away — outside a typical 20-trading-day hold.
See earnings−1.7% on average
From this point in the calendar, the next 20 trading days averaged −1.7% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Rentokil Initial closed at $23.91 on Nov 13, 2026, −10.3% over the past year, inside a 52-week range of $19.50 to $34.67.
Use the left and right arrow keys to read daily values.
Put RTO on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Rentokil Initial provides a broad range of business support services delivered through repeat visits to client sites across North America, the United Kingdom, Europe, Asia, and the Pacific. It is widely recognised for its pest control work, covering rodents, insects, and wildlife for both households and businesses, alongside hygiene offerings such as soap and sanitiser dispensers, air purification, feminine hygiene units, and floor mats.
The company also supplies and launders workwear, uniforms, and protective clothing, including cleanroom garments, and maintains plant displays, floral arrangements, seasonal decorations, and scenting systems for commercial premises. Its property care work spans damp proofing, conservation, and treatment of woodworm and wood rot, while its specialist cleaning services cover deep cleaning, graffiti and trauma cleaning, flood and fire restoration, industrial cleaning, and disinfection of hazardous sites. It further manages healthcare waste, including hazardous and offensive medical waste and sharps disposal.
Founded in 1903 and headquartered in Crawley, United Kingdom, Rentokil Initial trades under the ticker RTO.
Rentokil Initial’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 51.5, in the Neutral zone, up 0.3 points over five sessions.
Up 0.3 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 60 | 0.0% | +0.4% | ||
| Accumulation | 189 | +0.1% | +1.2% | ||
| Neutral (current zone) | 379 | −0.1% | −1.2% | ||
| Distribution | 27 | −1.0% | −2.3% | ||
| Selling | 0 | Not available | |||
Average RTO share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Rentokil Initial trades 36.4% below Gekko Fair Value of $37.58, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Rentokil Initial shares are worth, recalculated every trading day.
$37.58
Gekko Fair Value, Nov 14, 2026
36.4% Undervalued
At the end of Aug 2026 the price was 21.3% below the estimate.
No open-market insider purchases were filed for Rentokil Initial, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for RTO in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in RTO were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
0of the funds Gekko tracks hold RTO.
Rentokil Initial reports on Feb 25, 2027 (102 days away), and beat the EPS estimate in 1 of its last 8 reports.
Feb 25, 2027
102 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 30, 2026 | $0.39 est $0.66 | $3.59B est $3.53B | −20.6% |
| Mar 5, 2026 | $0.65 est $0.70 | $3.54B est $3.55B | +10.8% |
| Oct 23, 2025 | $0.00 est $0.00 | — | +8.2% |
| Jul 31, 2025 | $0.51 est $0.65 | $4.58B est $3.55B | +3.0% |
| Apr 17, 2025 | $0.04 est $0.00 | $3.53B est $3.50B | +5.1% |
| Oct 17, 2024 | $0.49 est $0.71 | $3.42B est $3.45B | +7.9% |
| Jul 25, 2024 | $0.00 est $0.00 | — | −0.8% |
| Apr 18, 2024 | $0.00 est $0.00 | $3.42B est $3.38B | −6.4% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Rentokil Initial is $30.70, +28.4% from the last close, from 1 firm rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 1 firm.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 12 | Bank of America Securities | $5.50 | −77.0% |
| Sep 22 | Bank of America Securities | — | — |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Rentokil Initial averaged −1.7% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.1% | 3 of 5 |
| Next 10 trading days | +0.1% | 2 of 5 |
| Next 15 trading days | +0.5% | 3 of 5 |
| Next 20 trading days | −1.7% | 2 of 5 |
| Next 30 trading days | +0.5% | 1 of 5 |
For scale, RTO’s typical 20-trading-day move in either direction is about 5.4%.
Rentokil Initial’s market cap is $12.05B, with a P/E ratio of 37.7 and revenue of $7.13B over the last twelve months.
Coverage of Rentokil Initial this week reads neutral: 2 positive, 3 neutral and 1 negative headlines.
Rentokil Initial’s market cap is $12.05B at the Nov 13, 2026 close of $23.91, with 502.4M shares outstanding. The shares trade on a P/E ratio of 37.7.
The consensus analyst 12-month price target for Rentokil Initial is $30.70, +28.4% from the last close. Of the 1 firm that rated the stock in the last 90 days, 1 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Rentokil Initial is undervalued: the Nov 13, 2026 close of $23.91 is 36.4% below Gekko Fair Value of $37.58. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Rentokil Initial is expected to report on Feb 25, 2027 (102 days away). Analysts expect earnings of $0.65 per share on revenue of $3.65B. Rentokil Initial beat the earnings estimate in 1 of its last 8 reports, moving 7.9% on average across the report.
Rentokil Initial’s 52-week high is $34.67 and its 52-week low is $19.50; it closed at $23.91 on Nov 13, 2026, −10.3% over the past year. Over the last five years the shares peaked at $43.25 on Nov 19, 2021.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (fair value and earnings risk), 2 as mixed (trend and gekkoindex) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.